with ai seppo kopsala founder and ceo 19 3 2018 our
play

With AI Seppo Kopsala Founder and CEO 19.3.2018 OUR MISSION To - PowerPoint PPT Presentation

With AI Seppo Kopsala Founder and CEO 19.3.2018 OUR MISSION To provide most effective solutions for screening of blinding eye diseases WE ARE OPTOMED HEADQUARTERS Oulu, Finland OPTOMED CHINA Shanghai DIABETES IS THE FASTEST GROWING


  1. With AI Seppo Kopsala Founder and CEO 19.3.2018

  2. OUR MISSION ”To provide most effective solutions for screening of blinding eye diseases”

  3. WE ARE OPTOMED HEADQUARTERS Oulu, Finland OPTOMED CHINA Shanghai

  4. DIABETES IS THE FASTEST GROWING REASON FOR WORLD 592 M BLINDNESS living with diabetes in 2035 WORLD • 35% of diabetics will suffer vision loss 382 M AFR 109.1% MENA 96.2% • Screening and early treatment is the only way to prevent blindness SEA 70.6% SACA 59.8% • 1 billion eye screenings would need to be done every year WP 46% • All countries are currently implementing extensive NAC 37.3% screening programs for diabetic retinopathy EUR 22.4% 2013 2035 • Eye screening market is today 5BUSD

  5. TRADITIONAL WAY TO DO OUR WAY TO DO SCREENING: Hand-held cameras connected to SCREENING OF BLINDING automatic diagnosis service EYE DISEASES

  6. Enabling eye screenings also in primary care 10% Ophtalmologists Available only for few. 90% Primary care Over 100 years same methods.

  7. Optomed business plan KEY GOAL 2: Get high quality retinal camera production cost below 1000USD POINT B KEY GOAL 3: Affordable eye Provide screening platform with screenings for all. automated diagnosis (AI) capability KEY GOAL 1: Commericalize ISO 10940 fulfilling hand held retinal POINT A camera. (Reached 2014) Optomed Smartscope-X established. Full product family R&D and Market entry with first product Phase 2 (2014 -  ) Phase 3 (2018  ) Phase 1 (2005-2013) Figure out how to make high quality low cost Commercialize complete product portfolio, Commercialize Smartscope-X that can reach and hand held retinal camera. and build financially strong company. screen all people in the world.

  8. THE FUTURE: EU Horizon 2020 funding for Smartscope X project • EU Horizon 2020 funding total 2MEUR (2017-2019) • Smartscope X = Our new hand held retinal camera with automatic diagnosis capability for eye diseases • Easy to use, effective screening, no experience needed on grading retinal images. AI +

  9. Optomed Oy Yrttipellontie 1, 90230 Oulu, Finland Tel: +358 20 741 3380 Info@optomed.com www.optomed.com Designed in Finland

Recommend


More recommend